4//SEC Filing
AMGEN INC 4
Accession 0001127602-12-024328
$AMGNCIK 0000318154operating
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 6:56 PM ET
Size
7.2 KB
Accession
0001127602-12-024328
Insider Transaction Report
Form 4
AMGEN INCAMGN
REASON J PAUL
Director
Transactions
- Sale
Common Stock
2012-08-09$81.93/sh−4,500$368,692→ 23,591 total
Footnotes (2)
- [F1]The price reported is an average price. The prices ranged from $81.931 to $81.932 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer.
- [F2]These shares include 124 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's unvested, and vested but deferred, Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.
Issuer
AMGEN INC
CIK 0000318154
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000318154
Filing Metadata
- Form type
- 4
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 6:56 PM ET
- Size
- 7.2 KB